Nomination committee

Dicot Pharma’s Nomination Committee is responsible for preparing and presenting proposals for the next Annual General Meeting. Its mandate includes proposals for the Chairman of the Board, Board members, Board remuneration (broken down by the Chairman, members, and any committees), the Chairman of the Annual General Meeting, auditor fees, and the election of auditors. The Nomination Committee’s proposals are submitted in conjunction with the notice of the upcoming Annual General Meeting.

The Nomination Committee is appointed by the Chairman of the Board contacting the three largest shareholders by voting rights as of September 30, 2026, each of whom appoints one member of the Nomination Committee. In the event that any of these shareholders does not wish to appoint a member, the fourth-largest shareholder and so on shall be consulted until the Nomination Committee consists of three members. The members of the Nomination Committee shall be announced on Dicot Pharma’s website no later than six months prior to the next Annual General Meeting. The website shall also include information on how shareholders may submit proposals to the Nomination Committee.